Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 195

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia

Open access
Than, Nandor Gabor, Romero, Roberto, Tarca, Adi Laurentiu, Kekesi, Katalin Adrienna, Xu, Yi, Xu, Zhonghui, Juhasz, Kata, Bhatti, Gaurav, Leavitt, Ron Joshua, Gelencser, Zsolt, Palhalmi, Janos, Chung, Tzu Hung, Gyorffy, Balazs Andras, Orosz, Laszlo, Demeter, Amanda, Szecsi, Anett, Hunyadi-Gulyas, Eva, Darula, Zsuzsanna, Simor, Attila, Eder, Katalin, Szabo, Szilvia, Topping, Vanessa, El-Azzamy, Haidy, LaJeunesse, Christopher, Balogh, Andrea, Szalai, Gabor, Land, Susan, Torok, Olga, Dong, Zhong, Kovalszky, Ilona, Falus, Andras, Meiri, Hamutal, Draghici, Sorin, Hassan, Sonia S., Chaiworapongsa, Tinnakorn, Krispin, Manuel, Knöfler, Martin, Erez, Offer, Burton, Graham J., Kim, Chong Jai, Juhasz, Gabor, Papp, Zoltan · 2018 · Frontiers in Immunology

Abstract

Preeclampsia is a disease of the mother, fetus and the placenta, and gaps in our understanding of the complex interactions among their disease pathways withheld successful treatment and prevention. The placenta has a key role in the pathogenesis of the terminal pathway characterized by exaggerated maternal systemic inflammation, generalized endothelial damage, hypertension and proteinuria. This sine qua non of preeclampsia may be triggered by distinct underlying mechanisms that occur at early stages of pregnancy and induce different phenotypes. To gain insights into these molecular pathways, we employed a systems biology approach and integrated different “omics”, clinical, placental, and functional data from patients with distinct phenotypes of preeclampsia. First trimester maternal blood proteomics uncovered altered abundance of proteins of the renin-angiotensin and immune systems, complement and coagulation cascades in both term and preterm preeclampsia patients. Moreover, first trimester maternal blood from preterm preeclampsia patients in vitro dysregulated trophoblastic gene expression. Placental transcriptomics of women with preterm preeclampsia identified distinct gene modules associated with maternal or fetal disease. Placental “virtual” liquid biopsy showed that the dysregulation of these disease gene modules originates already in the first trimester. In vitro experiments on hub transcription factors of these gene modules demonstrated that DNA hypermethylation in the regulatory region of ZNF554 leads to gene down-regulation and impaired trophoblast invasion, while BCL6 and ARNT2 up-regulation sensitizes the trophoblast to ischemia, hallmarks of preterm preeclampsia. In summary, our data suggests that there are distinct maternal and placental disease pathways, and their interaction influences the clinical presentation of preeclampsia. The activation of maternal disease pathways can be detected in all phenotypes of preeclampsia earlier and upstream of placental dysfunction, not only downstream as described before, and distinct placental disease pathways are superimposed on these maternal pathways. This is a paradigm shift, which, in agreement with epidemiological studies, warrants for the central pathologic role of preexisting maternal diseases or perturbed maternal-fetal-placental immune interactions in preeclampsia. The description of these novel pathways in the “molecular phase” of preeclampsia and the identification of their hub molecules may enable timely molecular characterization of patients with distinct preeclampsia phenotypes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2018.01661

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 195

Metadata

Authors
Than, N. G., Romero, R., Tarca, A. L., Kekesi, K. A., Xu, Y., Xu, Z., Juhasz, K., Bhatti, G., Leavitt, R. J., Gelencser, Z., Palhalmi, J., Chung, T. H., Gyorffy, B. A., Orosz, L., Demeter, A., Szecsi, A., Hunyadi-Gulyas, E., Darula, Z., Simor, A., Eder, K., Szabo, S., Topping, V., El-Azzamy, H., LaJeunesse, C., Balogh, A., Szalai, G., Land, S., Torok, O., Dong, Z., Kovalszky, I., Falus, A., Meiri, H., Draghici, S., Hassan, S. S., Chaiworapongsa, T., Krispin, M., Knöfler, M., Erez, O., Burton, G. J., Kim, C. J., Juhasz, G., & Papp, Z.
Venue
Frontiers in Immunology
Published
2018-08-08
Volume
9
Pages
1661-1661
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2850708907
Cited by
195
References
24
FWCI
19.55
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia. https://app.cochat.ai/papers/10.3389/fimmu.2018.01661
The paper
Than, N. G., Romero, R., Tarca, A. L., Kekesi, K. A., Xu, Y., Xu, Z., Juhasz, K., Bhatti, G., Leavitt, R. J., Gelencser, Z., Palhalmi, J., Chung, T. H., Gyorffy, B. A., Orosz, L., Demeter, A., Szecsi, A., Hunyadi-Gulyas, E., Darula, Z., Simor, A., . . . Papp, Z. (2018). Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2018.01661

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.